Risk of Government Budget Cuts and Reduced Capital Investment by Private-Sector Companies and Medical Institutions
First written in FY2016. 12 of 13 entries say "Restated". Latest entry: FY2024-Q1.
The whole theme swung hardest in 2020: 62 of 77 companies on the "Worse" side.
14 other companies' latest entry also says "Restated".
- FY2024-Q1RestatedAnnual report
「During the first quarter of the current fiscal year, there were no new occurrences of the major risks that management recognises could materially affect the financial position, operating results or cash flows of the Group among the matters relating to business conditions, financial conditions and other matters described in the quarterly report, and no material changes to the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
The Company explains that there have been no material changes in existing risks, including the risks of restrained orders from government bodies and local authorities and reduced capital investment. - FY2021-Q3RestatedAnnual report
「During the first three quarters of the current fiscal year, there were no new occurrences of the major risks that management recognises could materially affect the filing company's financial position, operating results or cash flows among the matters relating to business conditions, financial conditions and other matters described in the quarterly report, and no material changes to the "Business and Other Risks" described in the annual securities report for the previous fiscal year.」
No material changes have been reported regarding the risks of restrained orders from government bodies and local authorities or reduced capital investment by private-sector companies and medical institutions. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no new major risks that management recognizes could have a material impact on the financial condition, operating results or cash flows of the filing company, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
No material changes have been reported regarding the risks of restrained orders from government bodies and local authorities or reduced capital investment by private-sector companies and medical institutions. - FY2020-Q1RestatedAnnual report
「During the first quarter of the current fiscal year, no new business or other risks arose. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
No material changes have been reported regarding the risks of restrained orders from government bodies and local authorities or reduced capital investment by private-sector companies and medical institutions. - FY2019RestatedAnnual report
「If orders are curtailed as a result of reductions in national and local government budgets beyond expectations, or if private-sector companies and medical institutions reduce capital investment due to changes in economic conditions, this could affect the Company’s operating results.」
The Company continues to describe the risks of restrained orders from government bodies and local authorities and reduced capital investment by private-sector companies and medical institutions. - FY2019-Q1RestatedAnnual report
「During the first quarter of the current fiscal year, no new business or other risks arose. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
No material changes have been reported regarding the risks of restrained orders from government bodies and local authorities or reduced capital investment by private-sector companies and medical institutions. - FY2018RestatedAnnual report
「If orders are curtailed as a result of reductions in national and local government budgets beyond expectations, or if private-sector companies and medical institutions reduce capital investment due to changes in economic conditions, this could affect the Company’s operating results.」
The Company continues to identify restrained orders from government bodies and local authorities and reduced capital investment by private-sector companies and medical institutions as risks that could cause fluctuations in operating results. - FY2018-Q1RestatedAnnual report
「During the cumulative consolidated period for the first quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
No material changes have been reported regarding the risks of restrained orders from government bodies and local authorities or reduced capital investment by private-sector companies and medical institutions. - FY2017RestatedAnnual report
「If orders are curtailed as a result of reductions in national and local government budgets beyond expectations, or if private-sector companies and medical institutions reduce capital investment due to changes in economic conditions, this could affect the Group’s operating results.」
The risk of restrained orders from government bodies and local authorities and reduced capital investment by private-sector companies and medical institutions continues to be described in the full-year risk disclosures. - FY2017-Q3RestatedAnnual report
「During the cumulative third quarter, no new business or other risks arose. In addition, there were no material changes in the business and other risks described in the securities report for the previous fiscal year.」
No material changes have been reported regarding the risks of restrained orders from government bodies and local authorities or reduced capital investment by private-sector companies and medical institutions. - FY2017-Q2RestatedAnnual report
「During the cumulative second quarter, no new business or other risks arose. In addition, there were no material changes in the business and other risks described in the securities report for the previous fiscal year.」
No material changes have been reported regarding the risks of restrained orders from government bodies and local authorities or reduced capital investment by private-sector companies and medical institutions. - FY2017-Q1RestatedAnnual report
「During the cumulative consolidated period for the first quarter, no new business or other risks arose. There were also no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
No material changes have been reported regarding the risks of restrained orders from government bodies and local authorities or reduced capital investment by private-sector companies and medical institutions. - FY2016First statedAnnual report
「If orders are curtailed as a result of reductions in national and local government budgets beyond expectations, or if private-sector companies and medical institutions reduce capital investment due to changes in economic conditions, this could affect the Company’s operating results.」
The Company identifies restrained orders from government bodies and local authorities, as well as reduced capital investment by private-sector companies and medical institutions, as factors that could cause fluctuations in operating results.